INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
批准号:
2178851
负责人:
Mitchell P. Fink
金额:
$21.36万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-04-01 至 1996-03-31
关键词:
adenylate kinase allopurinol antioxidants bacterial disease biopsy blood toxicology cytoskeleton disease /disorder model endotoxins free radical scavengers gastrointestinal circulation gastrointestinal epithelium gastrointestinal toxin absorption intercellular connection intestinal mucosa ischemia lipopolysaccharides membrane permeability microelectrodes myeloperoxidase oxygen tension radiotracer septic shock swine
中文摘要
有人假设,在屏障功能的紊乱,
肠道使重症患者易于发生菌血症,
真菌血症和内毒素中毒。 上皮屏障的完整性可以
通过测量其对某些水溶性物质的渗透性来评估
化合物,如51 Cr-EDTA。 肠上皮细胞对
亲水性溶质的功能状态取决于
细胞间紧密连接(闭锁小带; ZO)。 最近的数据表明
ZO在解剖学和功能上与细胞骨架相连。
其他结果表明,组织的完整性,
细胞骨架依赖于维持足够的细胞内水平
的ATP。 由于细胞缺氧和氧化应激都可以干扰
ATP合成,我们假设脂多糖(LPS)诱导的
粘膜通透性过高是由肠上皮细胞中的ATP耗竭引起的。
因此,我们将研究缺血和氧化诱导的粘膜ATP
消耗作为内毒素对肠道的不利影响的机制
上皮通透性 拟议的研究将使用猪
内毒素中毒模型,令人满意地再现了许多血流动力学
在复苏的病人中感染性休克的表现。 粘膜
将通过测量血浆-管腔清除率来定量渗透性
51Cr-EDTA 将使用多导丝测量粘液氧合
允许监测O2的Clark型表面电极阵列
组织的多个微观半球(半径约20 μ M)中的张力。
使用这些方法,我们将评估LPS对细胞的时间依赖性影响。
粘膜氧合、ATP含量和渗透性。 此外,我们将
确定是否可以通过以下方法预防LPS诱导的粘膜通透性过高:
维持正常的上皮氧合,或者通过泵灌注
用含氧血液或灌注肠腔的血管供应
用含氧缓冲液清洗肠道 此外,我们还将研究
通过评估别嘌呤醇(一种黄嘌呤氧化酶)
抑制剂)或氧自由基清除剂,
内毒素动物体内ATP含量。 最后,我们将评估
粘膜缺氧或氧化应激对粘膜ATP含量和通透性的影响
正常的猪。 这些研究应该提供新的见解,
脓毒症中粘膜通透性过高的机制,
内毒素中毒
英文摘要
It has been hypothesized that derangements in the barrier function of the
gut predispose critically ill patients to the development of bacteremia,
fungemia, and endotoxicosis. The integrity of the epithelial barrier can
be assessed by measuring its permeability to certain water-soluble
compounds, such as 51Cr-EDTA. The permeability of the gut epithelium to
hydrophilic solutes is determined by the functional status of the
intercellular tight junctions (zonula occludens; ZO). Recent data suggest
that the ZO is anatomically and functionally linked to the cytoskeleton.
Other results indicate that the organizational integrity of the
cytoskeleton depends upon the maintenance of adequate intracellular levels
of ATP. Since both cellular hypoxia and oxidant stress can interfere with
ATP synthesis, we have hypothesized that lipopolysaccharide (LPS)-induced
mucosal hyperpermeability is caused by ATP depletion in enterocytes.
Accordingly, we will investigate ischemia- and oxidant-induced mucosal ATP
depletion as mechanisms for the adverse effect of endotoxin on gut
epithelial permeability. The proposed studies will utilize a porcine
endotoxicosis model that satisfactorily reproduces many of the hemodynamic
manifestations of septic shock in resuscitated patients. Mucosal
permeability will be quantitated by measuring the plasma-to-lumen clearance
of 51Cr-EDTA. Mucosal oxygenation will be measured using a multiwire
Clark-type surface electrode array that permits the monitoring of 02
tensions in multiple microscopic hemispheres (radius~20 uM) of tissue.
Using these methods, we will assess the time-dependent effects of LPS on
mucosal oxygenation, ATP content, and permeability. In addition, we will
determine whether LPS-induced mucosal hyperpermeability can be prevented by
maintaining normal epithelial oxygenation, either by pump-perfusing the
vascular supply of the gut with oxygenated blood or perfusing the lumen of
the gut with oxygenated buffer. Also, we will investigate the role of
oxidants by assessing the effects of allopurinol (a xanthine oxidase
inhibitor) or oxygen free-radical scavengers of mucosal permeability and
ATP content in endotoxic animals. Finally, we will assess the affects of
mucosal hypoxia or oxidant stress on mucosal ATP content and permeability
in normal pigs. These studies should provide new insights into the
mechanisms responsible for mucosal hyperpermeability in sepsis and
endotoxicosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR BASIS FOR EPITHELIAL BARRIER DYSFUNCTION/PROJECT 2
-
批准号:6829217
-
项目类别:
-
资助金额:$21.3万
-
财政年份:2004
-
负责人:Mitchell P. Fink
-
依托单位:
Ethyl Pyruvate: A Novel Treatment for Sepsis
-
批准号:6765286
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2003
-
负责人:Mitchell P. Fink
-
依托单位:
Ethyl Pyruvate: A Novel Treatment for Sepsis
-
批准号:6911508
-
项目类别:
-
资助金额:$31.9万
-
财政年份:2003
-
负责人:Mitchell P. Fink
-
依托单位:
Ethyl Pyruvate: A Novel Treatment for Sepsis
-
批准号:6669337
-
项目类别:
-
资助金额:$28.81万
-
财政年份:2003
-
负责人:Mitchell P. Fink
-
依托单位:
COMPLEMENT-DEPENDENT PROSTAGLANDIN SYNTHESIS IN SEPSIS
-
批准号:3466035
-
项目类别:
-
资助金额:$9.74万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
-
批准号:2178852
-
项目类别:
-
资助金额:$22.23万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
COMPLEMENT-DEPENDENT PROSTAGLANDIN SYNTHESIS IN SEPSIS
-
批准号:3466038
-
项目类别:
-
资助金额:$5.57万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
COMPLEMENT-DEPENDENT PROSTAGLANDIN SYNTHESIS IN SEPSIS
-
批准号:3466034
-
项目类别:
-
资助金额:$9.39万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
-
批准号:2684840
-
项目类别:
-
资助金额:$29.47万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
-
批准号:6197428
-
项目类别:
-
资助金额:$32.52万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
COMPLEMENT-DEPENDENT PROSTAGLANDIN SYNTHESIS IN SEPSIS
-
批准号:3466037
-
项目类别:
-
资助金额:$11.56万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
Intestinal Perfusion and Permeability in Sepsis
-
批准号:6785026
-
项目类别:
-
资助金额:$34.68万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
-
批准号:6519241
-
项目类别:
-
资助金额:$32.76万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
-
批准号:6603831
-
项目类别:
-
资助金额:$32.65万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
-
批准号:2900634
-
项目类别:
-
资助金额:$28.43万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
-
批准号:2392016
-
项目类别:
-
资助金额:$29.05万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
Intestinal Perfusion and Permeability in Sepsis
-
批准号:6873675
-
项目类别:
-
资助金额:$34.68万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
Intestinal Perfusion and Permeability in Sepsis
-
批准号:7089011
-
项目类别:
-
资助金额:$33.86万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
COMPLEMENT DEPENDENT PROSTAGLANDIN SYNTHESIS IN SEPSIS
-
批准号:3466039
-
项目类别:
-
资助金额:$6.58万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
COMPLEMENT-DEPENDENT PROSTAGLANDIN SYNTHESIS IN SEPSIS
-
批准号:3466036
-
项目类别:
-
资助金额:$9.71万
-
财政年份:1987
-
负责人:Mitchell P. Fink
-
依托单位:
国内基金
海外基金
Apocynin和allopurinol对运动上调自发性高血压大鼠肾脏一氧化氮合成酶表达的影响
-
批准号:81301667
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:曹鹏宇
-
依托单位: